Schroder Investment Management Group Has $44.41 Million Stake in Itron, Inc. $ITRI

Key Points

• Schroder Investment Management trimmed its stake by 5.2% to 356,531 shares—about a $44.41 million position (≈0.78% ownership); institutional investors collectively hold roughly 96.2% of Itron.
• Itron carries a Wall Street consensus of "Moderate Buy" with an average price target of $137.10 (8 Buys, 5 Holds), with recent analyst activity including Oppenheimer raising its target to $133 and Needham initiating coverage with a Buy at $124.
• Itron beat quarterly EPS estimates ($2.46 vs. $2.19) on $571.7M revenue (down 6.7% YoY) and guided FY2026 EPS to 5.75–6.25; the shares were trading around $91.96 with a P/E of ~14.1.

Schroder Investment Management Group cut its holdings in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 5.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 356,531 shares of the scientific and technical instruments company's stock after selling 19,556 shares during the quarter. Schroder Investment Management Group owned about 0.78% of Itron worth $44,410,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Campbell & CO Investment Adviser LLC acquired a new position in shares of Itron in the third quarter valued at approximately $1,300,000. Robeco Schweiz AG grew its holdings in Itron by 31.2% in the 3rd quarter. Robeco Schweiz AG now owns 372,176 shares of the scientific and technical instruments company's stock valued at $46,358,000 after buying an additional 88,504 shares in the last quarter. J. Safra Sarasin Holding AG bought a new position in Itron during the 3rd quarter worth $4,673,000. Envestnet Asset Management Inc. lifted its holdings in shares of Itron by 34.0% during the third quarter. Envestnet Asset Management Inc. now owns 148,317 shares of the scientific and technical instruments company's stock worth $18,474,000 after buying an additional 37,634 shares in the last quarter. Finally, Arvin Capital Management LP acquired a new stake in shares of Itron during the second quarter worth $8,331,000. Institutional investors own 96.19% of the company's stock.

Wall Street Analysts Forecast Growth

ITRI has been the topic of several research reports. Zacks Research upgraded shares of Itron from a "strong sell" rating to a "hold" rating in a research note on Thursday, February 26th. Weiss Ratings lowered shares of Itron from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Monday, January 12th. Needham & Company LLC started coverage on shares of Itron in a report on Friday, March 6th. They set a "buy" rating and a $124.00 target price on the stock. Wall Street Zen downgraded shares of Itron from a "buy" rating to a "hold" rating in a research report on Wednesday, January 14th. Finally, Oppenheimer boosted their price target on Itron from $125.00 to $133.00 and gave the company an "outperform" rating in a research note on Wednesday, February 18th. Eight research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $137.10.

Itron Trading Down 1.2%

Shares of Itron stock opened at $91.96 on Thursday. The company has a quick ratio of 1.56, a current ratio of 1.80 and a debt-to-equity ratio of 0.45. Itron, Inc. has a 12-month low of $88.57 and a 12-month high of $142.00. The company has a market capitalization of $4.13 billion, a price-to-earnings ratio of 14.13, a PEG ratio of 0.81 and a beta of 1.44. The firm's 50-day moving average price is $97.46 and its two-hundred day moving average price is $107.18.

Itron (NASDAQ:ITRI - Get Free Report) last issued its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 EPS for the quarter, beating the consensus estimate of $2.19 by $0.27. Itron had a net margin of 12.72% and a return on equity of 20.04%. The company had revenue of $571.66 million during the quarter, compared to analysts' expectations of $561.31 million. During the same period in the previous year, the company earned $1.35 EPS. The business's revenue for the quarter was down 6.7% compared to the same quarter last year. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. On average, analysts forecast that Itron, Inc. will post 5.33 earnings per share for the current fiscal year.

Insider Buying and Selling at Itron

In other news, SVP Justin K. Patrick sold 4,930 shares of Itron stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $99.54, for a total value of $490,732.20. Following the transaction, the senior vice president owned 34,344 shares in the company, valued at approximately $3,418,601.76. This trade represents a 12.55% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Christopher E. Ware sold 4,486 shares of the company's stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $99.54, for a total value of $446,536.44. Following the sale, the senior vice president owned 31,806 shares of the company's stock, valued at approximately $3,165,969.24. This represents a 12.36% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 51,180 shares of company stock valued at $5,085,475. 1.45% of the stock is currently owned by insiders.

Key Stories Impacting Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Zacks raised its Q2 2027 EPS forecast to $1.71 from $1.66, suggesting improved expected momentum in 2027. MarketBeat: ITRI
• Positive Sentiment: Zacks materially increased its Q4 2026 estimate to $1.73 from $1.49, indicating stronger anticipated year‑end profitability. MarketBeat: ITRI
• Positive Sentiment: Zacks published a FY2028 EPS projection of $8.86, signaling upside expectations over the longer term. MarketBeat: ITRI
• Neutral Sentiment: Zacks kept a "Hold" rating on ITRI and left the consensus full‑year view near prior levels (the broader consensus remains ~ $5.33 FY). MarketBeat: ITRI
• Negative Sentiment: Zacks trimmed several near‑term estimates: Q1 2026 cut to $1.26 (from $1.41), Q2 2026 to $1.44 (from $1.51), Q3 2026 to $1.55 (from $1.60) and modestly reduced FY2026/FY2027 numbers — near‑term earnings downgrades can weigh on the share price. MarketBeat: ITRI
• Negative Sentiment: Short interest surged ~42.7% in February to ~4.88M shares (about 11% of the float) with a ~2.5 days‑to‑cover — this elevated shorting increases downside pressure and potential volatility.

Itron Company Profile

Itron, Inc NASDAQ: ITRI is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company's offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron's product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.